Maryland 2022 Regular Session

Maryland House Bill HB517

Introduced
1/21/22  

Caption

Consumer Health Access Program for Mental Health and Addiction Care - Establishment

Impact

The legislation initiates a three-year pilot program, funded by a dedicated Consumer Health Access Program Fund established by the bill. This fund will receive annual appropriations of $1,000,000 for fiscal years 2024 to 2026. By empowering a hub entity and several spoke and specialty entities, the bill seeks to improve health literacy and service accessibility for vulnerable populations, while also ensuring that services reflect the diversity of Maryland's demographics. This structure could lead to improved transparency and enhanced trust in the mental health system.

Summary

House Bill 517 establishes the Consumer Health Access Program for Mental Health and Addiction Care, aiming to assist Maryland residents in accessing mental health and substance use disorder services through public and private health insurance. The bill focuses on addressing barriers related to insurance coverage, promoting equitable access to care, and enhancing consumer education and outreach. This program will be vital for individuals, especially those facing difficulties in navigating the complex healthcare landscape associated with mental health and addiction services.

Contention

One of the notable discussion points surrounding HB 517 includes the potential effectiveness of the program in achieving its goals, particularly in a landscape where mental health services are often underfunded and inequitable. Critics may express concerns about whether the allocated funds and program structure will be sufficient to bridge existing gaps in service delivery. Furthermore, there may be apprehensions regarding the ability of the funded entities to operate effectively without becoming entangled in conflicts of interest or sacrificing service quality for the sake of operational efficiency, as indicated by the requirement for conflict of interest policies.

Companion Bills

MD SB460

Crossfiled Health - Insurance Coverage Information

Similar Bills

MD SB1009

Task Force on Responsible Use of Natural Psychedelic Substances

MD HB548

Task Force on Responsible Use of Natural Psychedelic Substances

MD HB1057

Task Force to Study the Use and Possession of De Minimis Quantities of Controlled Dangerous Substances

MD HB1066

Commission on Behavioral Health Care Treatment and Access - Workgroups

MD SB460

Health - Insurance Coverage Information

MD HB794

Public Health – Opioid Restitution Fund Advisory Council

MD HB1229

Public Health - Kratom Consumer Protection Act

MD SB196

Maryland Department of Health - Overdose Report